ATS' Dermagraft Unapprovable For Diabetic Foot Ulcers Without New Study

Advanced Tissue Sciences is discussing with FDA the design of an additional clinical trial that the agency is requiring prior to approval of the firm's Dermagraft bioengineered human skin graft in the treatment of diabetic foot ulcers.